Center for Substance Abuse Prevention; Notice of Meeting, 40163 [2017-17963]

Download as PDF rmajette on DSKBCKNHB2PROD with NOTICES Federal Register / Vol. 82, No. 163 / Thursday, August 24, 2017 / Notices Date: September 26–27, 2017. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue Bethesda, MD 20814. Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892–9750, 240–276–6343, schweinfestcw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel Emerging Questions in Cancer Systems Biology. Date: September 28, 2017. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at Chevy Chase Pavilion, 4300 Military Road, Washington, DC 20015. Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W104, Bethesda, MD 20892–9750, 240–276–6342, choe@ mail.nih.gov. Name of Committee: National Cancer Institute Initial Review Group Subcommittee J—Career Development. Date: October 17–18, 2017. Time: 6:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Bethesda, MD 20892–9750, 240–276–6132, tushar.deb@nih.gov. Name of Committee: National Cancer Institute Initial Review Group Subcommittee F—Institutional Training and Education. Date: October 23–24, 2017. Time: 7:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Timothy C. Meeker, M.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Bethesda, MD 20892–9750, 240–276–6464, meekert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) VerDate Sep<11>2014 15:29 Aug 23, 2017 Jkt 241001 Dated: August 18, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–17891 Filed 8–23–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet in person and via web conference on September 19, 2017, from 9:30am to 5:00pm EDT and September 20, 2017, from 9:30am to 2:00pm EDT. The Board will meet in open session on September 19, 2017, from 9:30am to 12:45pm to provide updates on the Mandatory Guidelines for Federal Workplace Drug Testing Programs, present a study on the degradation of deoxyribose nucleic acid (DNA) in urine and oral fluid specimens, results from the opioid implementation performance testing (PT) samples, lessons learned from the pilot PT program for oral fluid, and the detection of opioid glucuronides in drug user hair. Public comments are welcome. If you intend to provide public comments, please register and provide a summary of your comments to the contact listed below. The Division of Workplace Programs will review public comments to ensure that they address the topics scheduled to be discussed during the meeting and adhere to the meeting’s established time limits for public comments. The board will meet in closed session on September 19, 2017, from 2:00pm to 5:00pm EDT and on September 20, 2017, from 9:30am to 2:00pm EDT to hear about current confidential practices in the hair testing industry and to discuss proposed revisions of the Oral Fluid Mandatory Guidelines for Federal Workplace Drug Testing Programs. These portions of the meeting are closed to the public as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d). To obtain the web conference call-in numbers and access codes, registration can be completed online at https:// snacregister.samhsa.gov/ MeetingList.aspx. PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 40163 Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees Web site, https:// www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab, or by contacting Brian Makela. Committee Name: Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Prevention Drug Testing Advisory Board Dates/Time/Type: September 19, 2017, from 9:30am to 12:45pm, EDT: Open, September 19, 2017, from 2:00pm to 5:00pm, EDT: Closed, September 20, 2017, from 9:30am to 2:00pm, EDT: Closed Place: Parklawn Building, Rooom 5E29, 5600 Fishers Lane, Rockville, Maryland 20857 Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240– 276–2600, Fax: 240–276–2610, Email: brian.makela@samhsa.hhs.gov. Brian Makela, Chemist, Substance Abuse and Mental Health Services Administration. [FR Doc. 2017–17963 Filed 8–23–17; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2017–0723] Public Workshop on Marine Technology and Standards Coast Guard, DHS. Notice; correction. AGENCY: ACTION: The Coast Guard is correcting a notice that appeared in the Federal Register of August 8, 2017. The document announced an upcoming Public Workshop on Marine Technology and Standards to be held on October 16 and 17, 2017 in Washington, DC. The document had an incorrect amount for the registration fee. FOR FURTHER INFORMATION CONTACT: If you have questions about this notice, contact Wayne Lundy, Office of Design and Engineering Standards, USCG, by telephone at (202) 372–1379 or email: Wayne.M.Lundy@uscg.mil. SUPPLEMENTARY INFORMATION: In the Federal Register of August 8, 2017 (82 FR 37104), the Coast Guard published a notice announcing a Public Workshop on Marine Technology and Standards. SUMMARY: E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 82, Number 163 (Thursday, August 24, 2017)]
[Notices]
[Page 40163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17963]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet in person and via web conference on September 
19, 2017, from 9:30am to 5:00pm EDT and September 20, 2017, from 9:30am 
to 2:00pm EDT.
    The Board will meet in open session on September 19, 2017, from 
9:30am to 12:45pm to provide updates on the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs, present a study on the 
degradation of deoxyribose nucleic acid (DNA) in urine and oral fluid 
specimens, results from the opioid implementation performance testing 
(PT) samples, lessons learned from the pilot PT program for oral fluid, 
and the detection of opioid glucuronides in drug user hair. Public 
comments are welcome. If you intend to provide public comments, please 
register and provide a summary of your comments to the contact listed 
below. The Division of Workplace Programs will review public comments 
to ensure that they address the topics scheduled to be discussed during 
the meeting and adhere to the meeting's established time limits for 
public comments.
    The board will meet in closed session on September 19, 2017, from 
2:00pm to 5:00pm EDT and on September 20, 2017, from 9:30am to 2:00pm 
EDT to hear about current confidential practices in the hair testing 
industry and to discuss proposed revisions of the Oral Fluid Mandatory 
Guidelines for Federal Workplace Drug Testing Programs. These portions 
of the meeting are closed to the public as determined by the 
Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and 
(9)(B), and 5 U.S.C. App. 2, Section 10(d).
    To obtain the web conference call-in numbers and access codes, 
registration can be completed online at https://snacregister.samhsa.gov/MeetingList.aspx.
    Meeting information and a roster of DTAB members may be obtained by 
accessing the SAMHSA Advisory Committees Web site, https://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab, or by contacting Brian Makela.

Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention Drug Testing 
Advisory Board
Dates/Time/Type: September 19, 2017, from 9:30am to 12:45pm, EDT: Open, 
September 19, 2017, from 2:00pm to 5:00pm, EDT: Closed, September 20, 
2017, from 9:30am to 2:00pm, EDT: Closed
Place: Parklawn Building, Rooom 5E29, 5600 Fishers Lane, Rockville, 
Maryland 20857
Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers 
Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240-276-2600, 
Fax: 240-276-2610, Email: brian.makela@samhsa.hhs.gov.

Brian Makela,
Chemist, Substance Abuse and Mental Health Services Administration.
[FR Doc. 2017-17963 Filed 8-23-17; 8:45 am]
 BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.